OncoSynergy
  • Clinical Trials
  • Science
    • Overview
    • Scientific Advisory Board
    • Pipeline
  • News
  • About
    • Our Mission
    • Our Team
    • Glioblastoma
  • Connect
    • Fundraisers
    • Contact Us
Press enter to begin your search
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

Company Info

Stamford, CT, 06903, USA
info@oncosynergy.com

SSL CERTIFICATE

Latest News

  • FDA Grants Third Orphan Drug Designation for OS2966 May 3, 2024
  • OncoSynergy Announces First Patient Treated in First-in-Human Clinical Trial of OS2966 in Recurrent Glioblastoma April 16, 2021
  • OncoSynergy Launches Phase I Trial for Patients With Recurrent Glioblastoma November 17, 2020

© 2024 OncoSynergy. All Rights Reserved by OncoSynergy, Inc

  • Clinical Trials
  • Science
    • Overview
    • Scientific Advisory Board
    • Pipeline
  • News
  • About
    • Our Mission
    • Our Team
    • Glioblastoma
  • Connect
    • Fundraisers
    • Contact Us